Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Kidney International. Supplement
|
December 1, 1995
What is the role of lipid lowering therapy in heart-allograft failure?
B Reichart, B M Meiser, K Wenke, et al.
The Clinical Investigator
|
September 1, 1992
Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration
C H Spes, C E Angermann, H U Stempfle, et al.
Plant, Cell & Environment
|
April 3, 2014
Biogenic volatile emissions from the soil
J Peñuelas, D Asensio, D Tholl, et al.
Scientific Reports
|
August 28, 2015
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut
H Prüss, J Leubner, N K Wenke, et al.
Circulation
|
October 7, 1997
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial
K Wenke, B Meiser, J Thiery, et al.
The Thoracic and Cardiovascular Surgeon
|
January 18, 2008
Cardiac surgery for octogenarians--a suitable procedure? Twelve-year operative and post-hospital mortality in 641 patients over 80 years of age
F W Schmidtler, I Tischler, M Lieber, et al.
The Journal of Heart Transplantation
|
November 1, 1990
Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection
A Schuetz, S Fritsch, B M Kemkes, et al.
Developmental Biology
|
August 17, 2017
Wnt signaling positively regulates endothelial cell fate specification in the Fli1a-positive progenitor population via Lef1
Kathleen Hübner, Kathrin S Grassme, Jyoti Rao, et al.
Genome Biology
|
December 15, 2021
Flimma: a federated and privacy-aware tool for differential gene expression analysis
Olga Zolotareva, Reza Nasirigerdeh, Julian Matschinske, et al.
Nature Communications
|
July 16, 2020
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sepideh Sadegh, Julian Matschinske, David B Blumenthal, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Kidney International. Supplement
|
December 1, 1995
What is the role of lipid lowering therapy in heart-allograft failure?
B Reichart, B M Meiser, K Wenke, et al.
The Clinical Investigator
|
September 1, 1992
Sulfadiazine therapy for toxoplasmosis in heart transplant recipients decreases cyclosporine concentration
C H Spes, C E Angermann, H U Stempfle, et al.
Plant, Cell & Environment
|
April 3, 2014
Biogenic volatile emissions from the soil
J Peñuelas, D Asensio, D Tholl, et al.
Scientific Reports
|
August 28, 2015
Anti-NMDA Receptor Encephalitis in the Polar Bear (Ursus maritimus) Knut
H Prüss, J Leubner, N K Wenke, et al.
Circulation
|
October 7, 1997
Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial
K Wenke, B Meiser, J Thiery, et al.
The Thoracic and Cardiovascular Surgeon
|
January 18, 2008
Cardiac surgery for octogenarians--a suitable procedure? Twelve-year operative and post-hospital mortality in 641 patients over 80 years of age
F W Schmidtler, I Tischler, M Lieber, et al.
The Journal of Heart Transplantation
|
November 1, 1990
Antimyosin monoclonal antibodies for early detection of cardiac allograft rejection
A Schuetz, S Fritsch, B M Kemkes, et al.
Developmental Biology
|
August 17, 2017
Wnt signaling positively regulates endothelial cell fate specification in the Fli1a-positive progenitor population via Lef1
Kathleen Hübner, Kathrin S Grassme, Jyoti Rao, et al.
Genome Biology
|
December 15, 2021
Flimma: a federated and privacy-aware tool for differential gene expression analysis
Olga Zolotareva, Reza Nasirigerdeh, Julian Matschinske, et al.
Nature Communications
|
July 16, 2020
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sepideh Sadegh, Julian Matschinske, David B Blumenthal, et al.
Page
of 3